Artal Group as of June 30, 2019
Portfolio Holdings for Artal Group
Artal Group holds 96 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals (LXRX) | 15.3 | $379M | 60M | 6.29 | |
| Weight Watchers International | 11.4 | $283M | 15M | 19.10 | |
| Avantor (AVTR) | 5.4 | $134M | 7.0M | 19.09 | |
| Alibaba Group Holding (BABA) | 4.5 | $110M | 650k | 169.45 | |
| Bristol Myers Squibb (BMY) | 4.1 | $102M | 2.3M | 45.35 | |
| NVIDIA Corporation (NVDA) | 3.5 | $85M | 520k | 164.23 | |
| Beigene (BGNE) | 3.3 | $81M | 650k | 123.95 | |
| Moderna (MRNA) | 3.0 | $75M | 5.1M | 14.64 | |
| Blueprint Medicines (BPMC) | 2.9 | $71M | 750k | 94.33 | |
| Acceleron Pharma | 2.5 | $62M | 1.5M | 41.08 | |
| Zillow Group Inc Cl C Cap Stk (Z) | 1.9 | $46M | 1.0M | 46.39 | |
| Rubius Therapeutics | 1.8 | $45M | 2.8M | 15.73 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $40M | 550k | 72.56 | |
| General Motors Company (GM) | 1.6 | $39M | 1.0M | 38.53 | |
| Scholar Rock Hldg Corp (SRRK) | 1.5 | $37M | 2.3M | 15.86 | |
| Medicines Company | 1.5 | $37M | 1.0M | 36.47 | |
| Gossamer Bio (GOSS) | 1.4 | $36M | 1.6M | 22.18 | |
| Amicus Therapeutics (FOLD) | 1.3 | $31M | 2.5M | 12.48 | |
| Argenx Se (ARGX) | 1.3 | $31M | 220k | 141.58 | |
| Fate Therapeutics (FATE) | 1.2 | $31M | 1.5M | 20.30 | |
| Agios Pharmaceuticals (AGIO) | 1.2 | $30M | 600k | 49.88 | |
| Nektar Therapeutics (NKTR) | 1.1 | $29M | 800k | 35.58 | |
| Sage Therapeutics (SAGE) | 1.1 | $28M | 150k | 183.09 | |
| Atara Biotherapeutics (ATRA) | 0.9 | $23M | 1.2M | 20.11 | |
| Uber Technologies (UBER) | 0.9 | $23M | 500k | 46.38 | |
| Melco Crown Entertainment (MLCO) | 0.9 | $22M | 1.0M | 21.72 | |
| Incyte Corporation (INCY) | 0.9 | $21M | 250k | 84.96 | |
| Epizyme | 0.8 | $21M | 1.7M | 12.55 | |
| Ascendis Pharma A S (ASND) | 0.7 | $17M | 150k | 115.15 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $17M | 700k | 24.52 | |
| Neurocrine Biosciences (NBIX) | 0.7 | $17M | 200k | 84.43 | |
| Nio Inc spon ads (NIO) | 0.7 | $17M | 6.6M | 2.55 | |
| American Airls (AAL) | 0.7 | $16M | 500k | 32.61 | |
| Dicerna Pharmaceuticals | 0.6 | $16M | 1.0M | 15.75 | |
| Cyclerion Therapeutics | 0.6 | $16M | 1.4M | 11.45 | |
| Mirati Therapeutics | 0.6 | $16M | 150k | 103.00 | |
| Albireo Pharma | 0.6 | $15M | 450k | 32.24 | |
| Tricida | 0.6 | $14M | 360k | 39.46 | |
| Audentes Therapeutics | 0.5 | $13M | 350k | 37.86 | |
| Bluebird Bio (BLUE) | 0.5 | $13M | 100k | 127.20 | |
| Huazhu Group (HTHT) | 0.5 | $13M | 350k | 36.25 | |
| Krystal Biotech (KRYS) | 0.5 | $12M | 300k | 40.27 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.5 | $12M | 1.3M | 9.10 | |
| Xencor (XNCR) | 0.5 | $11M | 275k | 40.93 | |
| Change Healthcare | 0.4 | $11M | 750k | 14.60 | |
| Accelr8 Technology | 0.4 | $10M | 450k | 22.88 | |
| Kaleido Biosciences Ord (KLDO) | 0.4 | $10M | 901k | 11.60 | |
| Alder Biopharmaceuticals | 0.4 | $10M | 850k | 11.77 | |
| Morphic Hldg (MORF) | 0.4 | $9.9M | 500k | 19.82 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.4 | $9.7M | 200k | 48.30 | |
| Translate Bio | 0.4 | $9.5M | 750k | 12.63 | |
| Y Mabs Therapeutics (YMAB) | 0.4 | $9.1M | 400k | 22.87 | |
| Replimune Group (REPL) | 0.4 | $8.8M | 600k | 14.66 | |
| Stoneco (STNE) | 0.4 | $8.9M | 300k | 29.58 | |
| Denali Therapeutics (DNLI) | 0.3 | $8.3M | 400k | 20.76 | |
| Fibrogen (FGEN) | 0.3 | $8.1M | 180k | 45.18 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.3 | $8.1M | 500k | 16.10 | |
| Turning Point Therapeutics I | 0.3 | $8.1M | 200k | 40.70 | |
| ArQule | 0.3 | $7.7M | 700k | 11.01 | |
| Tg Therapeutics (TGTX) | 0.3 | $7.8M | 900k | 8.65 | |
| Hookipa Pharma Inc equity (HOOK) | 0.3 | $7.6M | 1.1M | 6.73 | |
| Agenus (AGEN) | 0.3 | $7.5M | 2.5M | 3.00 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $7.4M | 145k | 51.37 | |
| Solid Biosciences | 0.3 | $6.9M | 1.2M | 5.75 | |
| Tcr2 Therapeutics Inc cs | 0.3 | $7.0M | 490k | 14.31 | |
| Crowdstrike Hldgs Inc cl a (CRWD) | 0.3 | $6.8M | 100k | 68.29 | |
| Spero Therapeutics (SPRO) | 0.2 | $6.2M | 540k | 11.51 | |
| Gritstone Oncology Ord (GRTS) | 0.2 | $5.6M | 500k | 11.14 | |
| D Stemline Therapeutics | 0.2 | $5.5M | 360k | 15.32 | |
| Ac Immune Sa (ACIU) | 0.2 | $5.6M | 1.0M | 5.55 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $5.4M | 360k | 15.00 | |
| Allogene Therapeutics (ALLO) | 0.2 | $5.4M | 200k | 26.85 | |
| Bridgebio Pharma (BBIO) | 0.2 | $5.4M | 200k | 26.97 | |
| Merus N V (MRUS) | 0.2 | $5.1M | 350k | 14.65 | |
| Orchard Therapeutics Plc ads | 0.2 | $4.9M | 350k | 13.99 | |
| Crispr Therapeutics (CRSP) | 0.2 | $4.7M | 100k | 47.10 | |
| Sangamo Biosciences (SGMO) | 0.2 | $4.4M | 405k | 10.77 | |
| Frontdoor (FTDR) | 0.2 | $4.4M | 100k | 43.55 | |
| Alector (ALEC) | 0.2 | $4.3M | 225k | 19.00 | |
| Selecta Biosciences (RNAC) | 0.1 | $3.8M | 2.1M | 1.79 | |
| Madrigal Pharmaceuticals (MDGL) | 0.1 | $3.7M | 35k | 104.80 | |
| Restorbio | 0.1 | $3.7M | 360k | 10.20 | |
| Axcella Health Inc equity | 0.1 | $3.6M | 390k | 9.31 | |
| Twist Bioscience Corp (TWST) | 0.1 | $2.9M | 100k | 29.01 | |
| 111 Inc ads (YI) | 0.1 | $2.5M | 450k | 5.56 | |
| Arcus Biosciences Incorporated (RCUS) | 0.1 | $2.1M | 270k | 7.95 | |
| Akebia Therapeutics (AKBA) | 0.1 | $2.1M | 425k | 4.84 | |
| Aravive | 0.1 | $1.8M | 308k | 6.00 | |
| Aduro Biotech | 0.1 | $1.5M | 1.0M | 1.54 | |
| Avrobio Ord (AVRO) | 0.1 | $1.5M | 90k | 16.26 | |
| Ngm Biopharmaceuticals (NGM) | 0.1 | $1.5M | 100k | 14.64 | |
| Ironwood Pharmaceuticals (IRWD) | 0.1 | $1.2M | 111k | 10.94 | |
| Aeglea Biotherapeutics | 0.1 | $1.2M | 169k | 6.85 | |
| Viking Therapeutics (VKTX) | 0.0 | $830k | 100k | 8.30 | |
| Realreal (REAL) | 0.0 | $578k | 20k | 28.90 | |
| Magenta Therapeutics | 0.0 | $347k | 24k | 14.75 |
